Michael A. Zoccoli
Corporate Officer/Principal chez Celera Corp.
Profil
Michael A.
Zoccoli is a professional with a doctorate degree from Dartmouth College and an undergraduate degree from the University of Connecticut.
He is currently the VP & General Manager-IVD Products Business at Celera Corp.
He previously held the same position at Celera Group from 2002 to 2011.
He also worked as a Vice President-Development & Manufacturing at Applied Biosystems, Inc. and held Principal positions at Applied Imaging Corp., Bayer Diagnostics Corp., Cetus Corp., and Roche Molecular Systems, Inc.
Postes actifs de Michael A. Zoccoli
| Sociétés | Poste | Début |
|---|---|---|
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Corporate Officer/Principal | 01/02/2008 |
Anciens postes connus de Michael A. Zoccoli
| Sociétés | Poste | Fin |
|---|---|---|
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | 15/04/2011 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | - |
| Bayer Diagnostics Corp. | Corporate Officer/Principal | - |
Applied Imaging Corp.
 Applied Imaging Corp. Medical SpecialtiesHealth Technology Applied Imaging Corp. designs and markets automated clinical analysis systems used by cytogenetic laboratories. It also supplies automated imaging systems, which are utilized in genetics and pathology laboratories for the detection & analysis of chromosomes in cancer and prenatal disorders. The company was founded in 1986 and is headquartered in San Jose, CA | Corporate Officer/Principal | - |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Corporate Officer/Principal | - |
Formation de Michael A. Zoccoli
| University of Connecticut | Undergraduate Degree |
| Dartmouth College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Celera Corp.
Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Health Services |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
| Cetus Corp. | Health Technology |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
Applied Imaging Corp.
Applied Imaging Corp. Medical SpecialtiesHealth Technology Applied Imaging Corp. designs and markets automated clinical analysis systems used by cytogenetic laboratories. It also supplies automated imaging systems, which are utilized in genetics and pathology laboratories for the detection & analysis of chromosomes in cancer and prenatal disorders. The company was founded in 1986 and is headquartered in San Jose, CA | Health Technology |
| Bayer Diagnostics Corp. | Health Technology |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |